Imprivata Leads Single Sign-On Category in KLAS 2013 Mid-Term Performance Review
Healthcare CIOs Laud Imprivata as a Strategic Long-Term Partner that Delivers Superior Technology and High-Quality Customer Service
Lexington, Mass.—June 19, 2013—Imprivata®, a leading global provider of healthcare IT security solutions, today announced that Imprivata OneSign® leads the single sign-on (SSO) category in the KLAS® 2013 Mid-Term Performance Review: Software & Services report. CIOs and other healthcare executives interviewed by KLAS laud Imprivata on the superior performance of its products and the quality of its customer service and support, and they indicate that Imprivata is integral to their long-term healthcare IT strategy.
“Imprivata is a strategic partner. The SSO product used in conjunction with smooth roaming creates an environment that is both efficient and highly valued by our users. Imprivata enables No Click Access® to clinical systems and patient information that delivers both security and convenience that clinicians need to better focus on patient care,” said Bruce Hall, CIO of Augusta Health, a 255-bed hospital in Fishersville, Va. “In addition, Imprivata understands the evolving healthcare IT landscape. We expect Imprivata will remain central to our healthcare IT strategy over the long term.”
The KLAS 2013 Mid-Term Performance Review: Software & Services report profiles hundreds of software and services vendors, providing a detailed look at the performance of each company's product line. The report aggregates performance data gathered over the past 12 months. The findings represent the voice of thousands of providers sharing their candid experience with various healthcare technology and vendors. Imprivata OneSign received a score of 88.4, building on the company’s momentum from 2012 when it was recognized as the SSO category leader in the KLAS 2012 Top 20 Best in KLAS Awards report.
“KLAS rankings are derived directly from customer input, so our consistently high scores serve as strong independent validation of Imprivata’s products, customer service and strategic importance,” said Ed Gaudet, chief marketing officer of Imprivata. “Imprivata also has the highest U.S. market share among SSO providers, according to HIMSS Analytics data, which supports feedback that we regularly receive from customers—Imprivata is the most widely-used application in hospitals after the electronic medical records system. Imprivata is simplifying healthcare IT to enable our customers with better focus on patient care.”
Imprivata, the leader in healthcare IT security, enables secure access and collaboration for two million healthcare users worldwide. As the #1 independent provider of single sign-on and access management solutions for healthcare and other regulated industries, Imprivata OneSign® Single Sign-On is exclusively endorsed by the American Hospital Association (AHA) and recognized by Gartner and KLAS. Imprivata Cortext® is the leading free HIPAA compliant text messaging solution for healthcare. Headquartered in Lexington, Massachusetts, Imprivata serves 1,300 hospitals in partnership with over 200 EMR and technology infrastructure vendors around the world. For more information, please visit www.imprivata.com.
All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners